Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Key Takeaways: Wegovy vs Ozempic Both medications contain identical active ingredient: semaglutide Wegovy is FDA-approved for weight loss, Ozempic is approved for type 2 diabetes Wegovys maximum dose is 2.4 mg weekly, Ozempic tops out at 2 mg weekly Clinical trials showing 14.9% average weight loss used Wegovys 2.4 mg dose Wegovy costs $1,349/month, Ozempic costs $969/month (both without insurance) Insurance often covers Ozempic for diabetes but denies Wegovy for weight loss Compounded semaglutide at $199/month offers same benefits at fraction of the cost Both cause similar side effects: nausea, diarrhea, constipation The Basics: What Are Wegovy and Ozempic
A 2025 meta-analysis in PMC (covering 36,754 tirzepatide and 106,057 semaglutide participants across multiple studies) confirmed tirzepatides advantage, finding an average 4.23 percentage points greater weight loss with tirzepatide an effect that was both dose- and duration-dependent
Patients may also discuss FDA-approved alternatives with their healthcare provider to understand all available options
was supported by NIDDK grants DK094006 and DK098246
A brand-new study out of Houston Methodist was the first to look specifically at people who are obese but not diabetic, which describes most women taking these drugs for weight loss
US$ 20.71
US$ 26.20
US$ 27.87
